Log In
Print this Print this

RO4917838, bitopertin (R1678, RG1678)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionGlycine transporter type 1 (GlyT1; SLC6A9) inhibitor
Molecular Target Glycine transporter type 1 (GlyT1) (SLC6A9)
Mechanism of ActionGlycine transporter type 1 (GlyT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationObsessive compulsive disorder (OCD)
Indication DetailsTreat obsessive compulsive disorder (OCD)
Regulatory Designation
PartnerChugai Pharmaceutical Co. Ltd.;
Genentech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today